Works about OLANZAPINE
Results: 2708
Quantitative evaluation of multiple treatment regimens for treatment-resistant depression.
- Published in:
- International Journal of Neuropsychopharmacology, 2025, v. 28, n. 2, p. 1, doi. 10.1093/ijnp/pyaf007
- By:
- Publication type:
- Article
Investigation of protective effects of olanzapine on impaired learning and memory using behavioral tests in a rat model of Alzheimer's disease.
- Published in:
- Frontiers in Aging Neuroscience, 2025, p. 1, doi. 10.3389/fnagi.2025.1376074
- By:
- Publication type:
- Article
Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial.
- Published in:
- Stem Cell Research & Therapy, 2025, v. 16, n. 1, p. 1, doi. 10.1186/s13287-025-04148-1
- By:
- Publication type:
- Article
A Bibliometric Analysis of Scientific Production on Second-Generation Anti-Psychotic Drugs in Malaysia.
- Published in:
- Malaysian Journal of Medical Sciences, 2018, v. 25, n. 3, p. 40, doi. 10.21315/mjms2018.25.3.5
- By:
- Publication type:
- Article
Decision models in the evaluation of psychotropic drugs.
- Published in:
- European Journal of Health Economics, 2006, v. 7, n. 3, p. 218, doi. 10.1007/s10198-006-0348-z
- By:
- Publication type:
- Article
Length of hospital stay and associated costs for olanzapine vs. haloperidol in the treatment of schizophrenia relapse in Germany.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 2, p. 85, doi. 10.1007/s10198-002-0161-2
- By:
- Publication type:
- Article
Olanzapine/samidorphan in schizophrenia and bipolar I disorder: a profile of its use in the USA.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 6, p. 253, doi. 10.1007/s40267-022-00919-5
- By:
- Publication type:
- Article
Psychotropic Treatment During Pregnancy: Research Synthesis and Clinical Care Principles.
- Published in:
- Journal of Women's Health (15409996), 2020, v. 29, n. 3, p. 310, doi. 10.1089/jwh.2019.7781
- By:
- Publication type:
- Article
Clinical update.
- Published in:
- Psycho-Oncology, 1999, v. 8, n. 1, p. 92, doi. 10.1002/(SICI)1099-1611(199901/02)8:1<92::AID-PON378>3.0.CO;2-N
- By:
- Publication type:
- Article
Effects of atypical antipsychotics on serum asprosin level and other metabolic parameters in patients with schizophrenia.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2024, v. 39, n. 5, p. 1, doi. 10.1002/hup.2907
- By:
- Publication type:
- Article
The impact of adjunctive aripiprazole on QT interval: A 12‐week open label study in patients on olanzapine, clozapine or risperidone.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2023, v. 38, n. 3, p. 1, doi. 10.1002/hup.2863
- By:
- Publication type:
- Article
The first patient to receive olanzapine: A recollection.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2021, v. 36, n. 6, p. 1, doi. 10.1002/hup.2823
- Publication type:
- Article
Safety and cardiovascular effects of multiple‐dose administration of aripiprazole and olanzapine in a randomised clinical trial.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2021, v. 36, n. 1, p. 1, doi. 10.1002/hup.2761
- By:
- Publication type:
- Article
Differential benefits of olanzapine on executive function in schizophrenia patients: Preliminary findings.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2020, v. 35, n. 1, p. N.PAG, doi. 10.1002/hup.2718
- By:
- Publication type:
- Article
Effects of olanzapine during cognitive and emotional processing in schizophrenia: A review of functional magnetic resonance imaging findings.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2019, v. 34, n. 3, p. N.PAG, doi. 10.1002/hup.2693
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2019, v. 34, n. 3, p. N.PAG, doi. 10.1002/hup.2669
- Publication type:
- Article
Does early antipsychotic response predict long-term treatment outcome?
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2017, v. 32, n. 6, p. n/a, doi. 10.1002/hup.2633
- By:
- Publication type:
- Article
Oral glucose tolerance test performance in olanzapine-treated schizophrenia-spectrum patients is predicted by BMI and triglycerides but not olanzapine dose or duration.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2017, v. 32, n. 4, p. n/a, doi. 10.1002/hup.2604
- By:
- Publication type:
- Article
The effects of olanzapine treatment on brain regional glucose metabolism in neuroleptic-naive first-episode schizophrenic patients.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 6, p. 419, doi. 10.1002/hup.2558
- By:
- Publication type:
- Article
Post authorization safety study comparing quetiapine to risperidone and olanzapine.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 4, p. 304, doi. 10.1002/hup.2539
- By:
- Publication type:
- Article
SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 3, p. 252, doi. 10.1002/hup.2532
- By:
- Publication type:
- Article
Individual differences in in vitro and in vivo metabolic clearances of the antipsychotic drug olanzapine from non-smoking and smoking Japanese subjects genotyped for cytochrome P4502D6 and flavincontaining monooxygenase 3.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 2, p. 83, doi. 10.1002/hup.2515
- By:
- Publication type:
- Article
Urine testing for antipsychotics: a pilot trial for a method to determine detection levels.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2015, v. 30, n. 5, p. 350, doi. 10.1002/hup.2482
- By:
- Publication type:
- Article
Olanzapine as the ideal 'trip terminator'? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance-related psychotic symptoms.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2015, v. 30, n. 4, p. 249, doi. 10.1002/hup.2431
- By:
- Publication type:
- Article
Olanzapine: evaluation of the in vivo cytogenetic effect.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2015, v. 30, n. 3, p. 189, doi. 10.1002/hup.2471
- By:
- Publication type:
- Article
A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2014, v. 29, n. 1, p. 83, doi. 10.1002/hup.2376
- By:
- Publication type:
- Article
Polymorphisms influencing olanzapine metabolism and adverse effects in healthy subjects.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2013, v. 28, n. 3, p. 205, doi. 10.1002/hup.2308
- By:
- Publication type:
- Article
Sex differences in the effect of four second-generation antipsychotics on QTc interval in patients with schizophrenia.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2013, v. 28, n. 3, p. 215, doi. 10.1002/hup.2309
- By:
- Publication type:
- Article
Changes in QT interval after switching to quetiapine in Japanese patients with schizophrenia.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2013, v. 28, n. 1, p. 94, doi. 10.1002/hup.2277
- By:
- Publication type:
- Article
Effects of olanzapine on <sup>31</sup>P MRS metabolic markers in schizophrenia.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2013, v. 28, n. 1, p. 91, doi. 10.1002/hup.2274
- By:
- Publication type:
- Article
Olanzapine and food craving: a case control study.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2013, v. 28, n. 1, p. 97, doi. 10.1002/hup.2278
- By:
- Publication type:
- Article
Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2012, v. 27, n. 4, p. 386, doi. 10.1002/hup.2238
- By:
- Publication type:
- Article
Effectiveness of two formulations of oral olanzapine in patients with schizophrenia or bipolar disorder in a natural setting: results from a 1-year European observational study.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2012, v. 27, n. 3, p. 284, doi. 10.1002/hup.2224
- By:
- Publication type:
- Article
Rapid and Sensitive LC-MS/MS Assay for Quantitation of Letrozole Using Solid-Phase Extraction from Human Blood Plasma and Its Application to Pharmacokinetic Studies.
- Published in:
- Pharmaceutical Chemistry Journal, 2014, v. 48, n. 4, p. 292, doi. 10.1007/s11094-014-1097-4
- By:
- Publication type:
- Article
Effects of Psychoeducation on Treatment Satisfaction in Schizophrenic Patients on Olanzapine Long Acting Injection.
- Published in:
- Archives of Psychiatry Research, 2022, v. 58, n. 1, p. 43, doi. 10.20471/may.2022.58.01.05
- By:
- Publication type:
- Article
Impact of the COVID-19 Pandemic on Healthcare Resource Utilization in Individuals with Major Depressive Disorder.
- Published in:
- Health Services Research & Managerial Epidemiology, 2022, v. 9, p. 1, doi. 10.1177/23333928221111864
- By:
- Publication type:
- Article
PREDICTING DRUG INTERACTIONS AND PHARMACOKINETIC VARIABILITY WITH IN VITRO METHODS: THE OLANZAPINE EXPERIENCE*.
- Published in:
- Drug Metabolism Reviews, 1999, v. 31, n. 1, p. 15, doi. 10.1081/DMR-100101905
- By:
- Publication type:
- Article
Predicting maintenance lithium response for bipolar disorder from electronic health records—a retrospective study.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.17841
- By:
- Publication type:
- Article
Risk factors for violent crime in patients with schizophrenia: a retrospective study.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.18014
- By:
- Publication type:
- Article
A Placebo-Controlled Add-On Trial of the Ampakine, CX516, for Cognitive Deficits in Schizophrenia.
- Published in:
- Neuropsychopharmacology, 2008, v. 33, n. 3, p. 465, doi. 10.1038/sj.npp.1301444
- By:
- Publication type:
- Article
D<sub>2</sub> Receptor Occupancy of Olanzapine Pamoate Depot Using Positron Emission Tomography: An Open-label Study in Patients with Schizophrenia.
- Published in:
- Neuropsychopharmacology, 2008, v. 33, n. 2, p. 298, doi. 10.1038/sj.npp.1301409
- By:
- Publication type:
- Article
Effect of Chronic Exposure to Antipsychotic Medication on Cell Numbers in the Parietal Cortex of Macaque Monkeys.
- Published in:
- Neuropsychopharmacology, 2007, v. 32, n. 6, p. 1216, doi. 10.1038/sj.npp.1301233
- By:
- Publication type:
- Article
Olanzapine-Induced Weight Gain and Increased Visceral Adiposity is Blocked by Melatonin Replacement Therapy in Rats.
- Published in:
- Neuropsychopharmacology, 2007, v. 32, n. 2, p. 284, doi. 10.1038/sj.npp.1301093
- By:
- Publication type:
- Article
Time Course of the Antipsychotic Effect and the Underlying Behavioral Mechanisms.
- Published in:
- Neuropsychopharmacology, 2007, v. 32, n. 2, p. 263, doi. 10.1038/sj.npp.1301110
- By:
- Publication type:
- Article
Olanzapine and S100 Proteins.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Olanzapine Upregulates Genes for S100A8 and S100A9 in the Frontal Cortex of Rats.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Effects of Atypical Antipsychotic Drugs on Intralipid Intake and Cocaine-Induced Hyperactivity in Rats.
- Published in:
- Neuropsychopharmacology, 2006, v. 31, n. 9, p. 1938, doi. 10.1038/sj.npp.1300949
- By:
- Publication type:
- Article
Chronic Olanzapine Treatment Causes Differential Expression of Genes in Frontal Cortex of Rats as Revealed by DNA Microarray Technique.
- Published in:
- Neuropsychopharmacology, 2006, v. 31, n. 9, p. 1888, doi. 10.1038/sj.npp.1301002
- By:
- Publication type:
- Article
The Effect of Olanzapine on Craving and Alcohol Consumption.
- Published in:
- Neuropsychopharmacology, 2006, v. 31, n. 6, p. 1310, doi. 10.1038/sj.npp.1300917
- By:
- Publication type:
- Article
Neurochemical Effects of Olanzapine in First-Hospitalization Manic Adolescents: A Proton Magnetic Resonance Spectroscopy Study.
- Published in:
- Neuropsychopharmacology, 2006, v. 31, n. 6, p. 1264, doi. 10.1038/sj.npp.1300950
- By:
- Publication type:
- Article